Sunday, November 1, 2026

Olympic Blunder: Australia’s 9NEWS Mixes Up South Korea with China

This time, an Australian broadcaster mistakenly displayed the Chinese flag instead of the South Korean flag.

SK Biopharmaceuticals Introduces 128 NVIDIA B200 GPUs, Accelerating AI-Driven Drug Discovery

SK Biopharmaceuticals has secured 128 NVIDIA B200 GPUs to build large-scale AI infrastructure, accelerate AI-driven drug discovery, strengthen TR-AX, and explore new AI-based research business models.

KCC Glass Unveils Award-Winning Glass Antenna Technology for Future Mobility

KCC Glass wins Best Paper Award for innovative vehicle glass-integrated antenna technology, outperforming major global companies.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.

Celltrion accelerates mechanism diversification strategy, expands autoimmune disease portfolio

Celltrion accelerates the development of biosimilars for autoimmune disease treatments, expanding its portfolio for long-term growth.

South Korea’s first single-port robotic gallbladder surgery study confirms safety

A study shows single-port robotic gallbladder surgery is faster than traditional laparoscopic methods while maintaining safety, promising less scarring.

Lunit Expands Global Reach: New AI Solutions for Breast Cancer Screening in the UK and U.S.

Lunit expands its global supply chain by securing contracts with major healthcare institutions in the UK and U.S. for AI solutions.

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.

Daedeok Innopolis expands biotech collaboration with Johns Hopkins and Harvard

The Daedeok Special Zone Foundation held a seminar on Korea-U.S. advanced bio-technology cooperation in Daejeon.

Celltrion expands U.S. PBM coverage, boosting outlook for high-margin biosimilars

Celltrion expands its listing with US PBM, enhancing its high-profit biosimilar product base and boosting sales expectations for H2.

SK Plasma launches Revolpac, expands rare blood disorder portfolio

SK Plasma launches 'Revolpak' for treating thrombocytopenia, expanding its portfolio in rare and severe blood disorders.

HLB Panagene Signs Exclusive PNA Distribution Agreement in Singapore With Roche Affiliate

HLB Panajin signs exclusive distribution deal for PNA with Roche Group's subsidiary, advancing its drug development efforts.

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.